Overview
Dr. Maunank Shah is Professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include infectious disease. Dr. Shah received his undergraduate degree in biology from the University of Virginia. He earned his M.D. from the University of California, San Francisco School of Medicine. He completed his residency at Emory University School of Medicine and performed a fellowship in infectious diseases at Johns Hopkins. Dr. Shah earned his Ph.D. in clinical investigation and public health, with expertise in decision-analysis, epidemiology, and biostatistics, from the Johns Hopkins Bloomberg School of Public Health. His research interests focus on innovation in HIV and TB care. He is the inventor of video-DOT software (Scene.health) now used for patient-centered adherence support in over 700 US health departments. He is also co-inventor of HIVASSIST (www.hivassist.com), an educational and decision-support application for individualized ARV selection for persons with HIV. He has also built decision support tools for latent TB infection, and other infectious diseases. He has led WHO evidence review for novel TB diagnostics including urinary LAM antigen tests, and developed JHEEM (Johns Hopkins Epidemiologic-Economic Model), chaired the NTCA guideline development for community based TB isolation recommendations. Dr. Shah is medical director for the Baltimore City Tuberculosis Program, and past-President of the National Society of TB Clinicians. He serves on the Maryland Tuberculosis Guidelines committee and is Deputy Editor for CID, the flagship clinical journal of the Infectious Disease Society of America. An author of more than 70 peer-reviewed studies, he is a member of the International Union for TB and Lung Disease, the International AIDS Society and the Infectious Diseases Society of America. Dr. Shah leads online infectious diseases educational activities in partnership with the JH Office of Online Education, is Director of Johns Hopkins IDEAL (Center for Infectious Diseases Education, Advancement and Learning), and serves as co-director for the microbiology and infectious disease curriculum for students at the Johns Hopkins School of Medicine.
Dr. Shah is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 1 peer reviewed article. Dr. Shah is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
Baltimore, MD 21224
1800 Orleans Street, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Johns Hopkins Hospital
Dr. Anna Durbin is an associate professor at the Johns Hopkins University School of Medicine. Her area of clinical expertise is infectious disease. Dr. Durbin earned her M.D. from Wayne State University School of Medicine. She completed her residency and performed a fellowship in infectious diseases at Detroit Medical Center. She has expertise in the evaluation of live attenuated flavivirus vaccines, primary dengue and West Nile virus vaccines, and the early evaluation of malaria vaccines. She has served on national and international advisory boards and committees related to dengue and malaria vaccine safety. An important research interest of hers is studying the immunopathogenesis of dengue infection and disease. In addition to her clinical studies, her laboratory is also developing an animal model of dengue using rhesus macaques. Dr. Durbin is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Dengue Fever, Viral Hemorrhagic Fever, Arbovirosis, and Yellow Fever. Dr. Durbin is board certified in American Board Of Internal Medicine. Dr. Durbin is currently accepting new patients.
Office
Kathleen Neuzil is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Neuzil is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Typhoid Fever, Salmonella Enterocolitis, Flu, and COVID-19.
The Johns Hopkins Hospital
Mark Sulkowski, MD, is a Professor of Medicine at the Johns Hopkins University School of Medicine and the Director of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center. He also serves as the Medical Director of the Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology in the Department of Medicine and is the Senior Associate Dean for Clinical Trials. He received his MD from Temple University School of Medicine, Philadelphia, PA (1992), pursued training in Internal Medicine at Duke University School of Medicine, Durham, NC (1995) and completed his Fellowship in Infectious Diseases (1998) at the Johns Hopkins University School of Medicine. Prof. Sulkowski has been the principal investigator for more than 120 clinical trials related to the management of viral hepatitis B and C in persons with and without HIV co-infection. He was the global principal investigator for more than a dozen trials, including the largest clinical trial of agents for the treatment of hepatitis C (New England Journal of Medicine, 2009) and the vanguard study of combination therapy with direct inhibitors of the HCV NS5A and NS5B non-structural proteins (New England Journal of Medicine, 2014). He is the past-chair of the Hepatitis Transformative Sciences Group of the National Institute of Health-funded adult AIDS Clinical Trials Group (ACTG) where he led translational studies of liver disease, namely hepatitis B and C virus. He is an elected member of the American Society for Clinical Investigation (2011) and the American Association of Physicians (2017). Prof. Sulkowski is a member of numerous professional societies including the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), and the Infectious Diseases Society of America (IDSA). With more than 300 peer-reviewed articles, he is widely published with works in Annals of Internal Medicine, New England Journal of Medicine, JAMA, Clinical Infectious Diseases, Journal of Hepatology, and Hepatology. In 2017, 2018 and 2019, he was named as a Highly Cited Researcher (Clarivate Analytics) defined as the being in the top 1% of global researchers in 21 fields of the sciences and social sciences based on the number of citations for papers. As an invited lecturer, he has been frequently invited to present at major national and international medical congresses and has educated learners in more than 25 countries. Dr. Sulkowski is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Hepatitis C, Hepatitis, HIV/AIDS, and Hepatitis B. Dr. Sulkowski is board certified in American Board Of Internal Medicine. Dr. Sulkowski is currently accepting new patients.
Frequently Asked Questions about Dr. Maunank R. Shah
How do I make an appointment with Dr. Maunank R. Shah?
You can book an appointment with Dr. Maunank R. Shah by calling their office at 410-550-0100. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Does Dr. Maunank R. Shah accept my insurance?
Dr. Maunank R. Shah accepts most major insurance plans, including Aetna and CareFirst. We recommend calling the office directly at 410-550-0100 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
We do not have enough information to identify the Areas of Expertise for this provider.